183 related articles for article (PubMed ID: 32908615)
1. A Comprehensive Exploration of the lncRNA CCAT2: A Pan-Cancer Analysis Based on 33 Cancer Types and 13285 Cases.
Huang B; Yu M; Guan R; Liu D; Hou B
Dis Markers; 2020; 2020():5354702. PubMed ID: 32908615
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of LncRNA PVT1 and Its Potential Target Gene Network in Human Cancers: a Comprehensive Inquiry Based Upon 21 Cancer Types and 9972 Cases.
He RQ; Qin MJ; Lin P; Luo YH; Ma J; Yang H; Hu XH; Chen G
Cell Physiol Biochem; 2018; 46(2):591-608. PubMed ID: 29617692
[TBL] [Abstract][Full Text] [Related]
3. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
Huang S; Qing C; Huang Z; Zhu Y
Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
[TBL] [Abstract][Full Text] [Related]
4. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
[TBL] [Abstract][Full Text] [Related]
5. High expression of long non-coding RNA CCAT2 indicates poor prognosis of gastric cancer and promotes cell proliferation and invasion.
Wu SW; Hao YP; Qiu JH; Zhang DB; Yu CG; Li WH
Minerva Med; 2017 Aug; 108(4):317-323. PubMed ID: 28248065
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
Chen X; Liu L; Zhu W
Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of long non‑coding RNA CCAT2 indicates a poor prognosis and promotes proliferation and metastasis in intrahepatic cholangiocarcinoma.
Bai JG; Tang RF; Shang JF; Qi S; Yu GD; Sun C
Mol Med Rep; 2018 Apr; 17(4):5328-5335. PubMed ID: 29393466
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
Li X; Xiao X; Chang R; Zhang C
J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
[TBL] [Abstract][Full Text] [Related]
10. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
Ruan R; Zhao XL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
12. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles.
Zhang Y; Liang C; Zhang Y; Wang Z; Li R; Wei Z; Guo J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140822
[TBL] [Abstract][Full Text] [Related]
13. lncRNA CCAT2 promotes radiotherapy resistance for human esophageal carcinoma cells via the miR‑145/p70S6K1 and p53 pathway.
Wang M; Wang L; He X; Zhang J; Zhu Z; Zhang M; Li X
Int J Oncol; 2020 Jan; 56(1):327-336. PubMed ID: 31789385
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CCAT2 predicts poor prognosis and regulates growth and metastasis in small cell lung cancer.
Chen S; Wu H; Lv N; Wang H; Wang Y; Tang Q; Shao H; Sun C
Biomed Pharmacother; 2016 Aug; 82():583-8. PubMed ID: 27470400
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinicopathological significance of CCAT2 in Chinese patients with various tumors.
Tian GW; Li N; Xin Y
Int J Biol Markers; 2017 Jul; 32(3):e344-e351. PubMed ID: 28623646
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1.
Liu Y; Wang D; Li Y; Yan S; Dang H; Yue H; Ling J; Chen F; Zhao Y; Gou L; Tang P; Huang A; Tang H
Exp Cell Res; 2019 Jun; 379(1):19-29. PubMed ID: 30922920
[TBL] [Abstract][Full Text] [Related]
17. CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 'gene desert', serve as important prognostic biomarkers in colorectal cancer.
Ozawa T; Matsuyama T; Toiyama Y; Takahashi N; Ishikawa T; Uetake H; Yamada Y; Kusunoki M; Calin G; Goel A
Ann Oncol; 2017 Aug; 28(8):1882-1888. PubMed ID: 28838211
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells.
Guo H; Hu G; Yang Q; Zhang P; Kuang W; Zhu X; Wu L
Oncotarget; 2016 Dec; 7(49):81806-81814. PubMed ID: 27833083
[TBL] [Abstract][Full Text] [Related]
19. Circulating long non-coding RNA colon cancer-associated transcript 2 protected by exosome as a potential biomarker for colorectal cancer.
Wang L; Duan W; Yan S; Xie Y; Wang C
Biomed Pharmacother; 2019 May; 113():108758. PubMed ID: 30877883
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA CCAT2 can predict metastasis and a poor prognosis: A meta-analysis.
Jing X; Liang H; Cui X; Han C; Hao C; Huo K
Clin Chim Acta; 2017 May; 468():159-165. PubMed ID: 28263738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]